-
The performance of Pian Tsai has declined, will the bet on Angong Beef Yellow Pill be successful?
Time of Update: 2022-10-31
Buffalo horn, early search for goods merchants will be more, the market continues to rise, after the high price is higher, in recent days small batch movement normal, the market remains firm running, the current market buffalo horn wire asking price between 30-35 yuan; The supply of tall people is still small, and the quotation is about 45 yuan.
-
Xi'an Quercus Ping Biology welcome consultation: Cnidium monnieri 10%-98% plant monomer
Time of Update: 2022-10-31
js?cdnversion='+~(-new Date()/36e5)]; Xi'an Quercus Ping Biology Welcome to consult: Cnidium monnieri 10%-98% Plant monomer composition Chinese Name: Cnidium monnieri Chinese synonyms: Cnidium monnieri seed; 7-Methoxy-8-isoprenyl coumarin; Cnidium monnieri (7-methoxy-8-isoprenyl coumarin) English name: Osthole CAS number: 484-12-8 Molecular Formula: C15H16O3 Molecular weight: 244.
-
In the next five years, the pharmaceutical chain retail industry will usher in rapid development!
Time of Update: 2022-10-31
In recent years, with the normalization of centralized procurement, the separation of medicines, graded diagnosis and treatment, and the continuous improvement of relevant policies in the field of In
-
Institutional research 3 pharmaceutical and biological companies have been surveyed by more than 100 institutions
Time of Update: 2022-10-31
【Pharmaceutical Network Industry News】In the past 5 days (October 18 to October 24), the institutional research stock shows that a total of 51 companies have been investigated by institutions, of which 8 are pharmaceutical and biological companies, namely Junshi Biologics, Walt Dyne, Propharmaceutical, Kai Medical, Poinsettia, Weili Medical, OPCOM Vision, and Zhenghai Biotechnology.
-
76 listed companies have been investigated by institutions, and the head of medical devices has been "stepped on the threshold"
Time of Update: 2022-10-31
com) This week (October 24-October 28), the pharmaceutical and biological industry is still favored by institutions, and the institutions have investigated a large number of companies including Yuyue Medical, Salubris, Puli Pharmaceutical, Chutian Technology, Kaikai Medical, RheinBiologics, Dirui Medical, etc.
-
15-valent pneumonia vaccine! EU approval of Vaxneuvance: for people aged 6 weeks - under 18 years old!
Time of Update: 2022-10-31
October 25, 2022 /BioValleyBIOON/ --Merck & Co has announced that the European Commission (EC) has approved Vaxneuvance (15-valent pneumococcal conjugate vaccine [PCV], V114) to expand its indication for active immunization of infants, children and adolescents aged 6 weeks to under 18 years of age to prevent invasive diseases, pneumonia and acute otitis media caused by 15 serotypes of Streptococcus pneumoniae 。 In the EU, Vaxneuvance has previously been approved for use in adults aged 18 and over.
-
Local pharmaceutical companies are innovating, and the competition for talents has been surging
Time of Update: 2022-10-31
js?cdnversion='+~(-new Date()/36e5)]; In recent years, with the promotion of the new medical reform policy, the domestic pharmaceutical industry has gradually upgraded from generic drugs to innovative drugs, and local pharmaceutical companies have accelerated the pace of innovation and transformation.
-
Recently, there have been frequent changes in senior management of multinational pharmaceutical companies
Time of Update: 2022-10-31
Since entering October, many multinational pharmaceutical companies, including Merck and GSK, have reported executive changes.
Since entering October, many multinational pharmaceutical companies, including Merck and GSK, have reported executive changes.
Since entering October, many multinational pharmaceutical companies, including Merck and GSK, have reported executive changes.
-
The pharmaceutical company's core technical staff left to be responsible for the company's clinical research in the United States full-time as a consultant
Time of Update: 2022-10-31
EDWARD JOW FANG JOINED MENGKE PHARMACEUTICAL IN 2017, AND BEFORE LEAVING HIS JOB, HE SERVED AS SENIOR VICE PRESIDENT OF MENGKE USA, AND WAS THE COMPANY'S CORE TECHNICAL PERSONNEL, MAINLY RESPONSIBLE FOR CARRYING OUT CLINICAL RESEARCH IN THE UNITED STATES.
-
Practice the evaluation indicators of high-quality development of public hospitals and continuously improve the capacity of medical services
Time of Update: 2022-10-31
In order to explore the path of improving medical service capacity, and at the same time grasp the opportunities of rapid digital development and promote the high-quality development of hospitals, Xinhuanet, together with Zhejiang Provincial People's Hospital and GlaxoSmithKline, a public welfare supporter, recently launched the 2022 National Hospital Presidents Salon of "Continuously Improving Medical Service Capabilities and Digitally Empowering High-quality Development of Hospitals", inviting ten public hospital leaders to have in-depth exchanges.
-
PD-L1 pioneer Zhan Lieping Startup, raised $65 million to treat cold tumors through immune normalization
Time of Update: 2022-10-31
Normunity is based on a drug discovery platform developed in Chan Lieping's lab, which allows it to tease out the complex interactions between tumors and the immune system to find new targets that no one else has discovered, and that help tumors form a protective barrier.
-
Quercus Pinnacle Bio supplies 1% 98% white potato extract industry dynamics
Time of Update: 2022-10-31
【Part of use】:Root of Ulgaris [Ingredients]: Euranthrin, isolutein, Baizhi polysaccharide 【Plant Distribution】:Nationwide 【Product Specifications】:Luteanocarbin 1% 50% 98% 【Detection Method】:HPLC 【 Product appearance]: brown yellow to off-white [product status]: fine powder [storage method]: sealed in a cool, dry place [packing]: aluminum foil bag 1kg/bag, 25kg/barrel or according to customer requirements [shelf life]: 24 months Quercus Ping Bio supplies Lutein 1% 98% White Pycnogenol Extract Industry News 1.
-
The Food and Drug Administration announced the full implementation of electronic registration certificates for medical devices
Time of Update: 2022-10-31
In order to implement the important decisions and deployments of the Party Central Committee and the State Council on deepening the reform of "decentralization, management and service", optimize the
-
The API industry has ushered in a period of opportunity, and pharmaceutical companies have accelerated their layout
Time of Update: 2022-10-31
On October 27, Zhongsheng Pharmaceutical issued an announcement that the API brofenac sodium of Xianqiang Pharmaceutical, a wholly-owned subsidiary, was approved for marketing by the State Food and Drug Administration.
-
Reply to the proposal on further strengthening the construction of the traceability system for traditional Chinese medicines
Time of Update: 2022-10-31
Member Wang Rui: After receiving the "Proposal on Further Strengthening the Construction of the Traceability System for Traditional Chinese Medicine" put forward, our bureau, together with the Minist
-
Henan has 10 national regional medical center projects
Time of Update: 2022-10-31
According to the construction plan, Peking University Sixth Hospital will rely on Henan Provincial Psychiatric Hospital (the second affiliated hospital of Xinxiang Medical College) to establish Henan Hospital, with 1,000 beds and 1,200 staffing.
-
During the disclosure period of the third quarterly report, the performance of the two major sectors of the pharmaceutical industry was eye-catching
Time of Update: 2022-10-31
As of October 26, Wind data shows that a total of 141 A-share biopharmaceutical companies have disclosed three quarterly reports, of which 84 companies have achieved a year-on-year increase in net profit attributable to the parent in the first three quarters, accounting for 59.
-
During the disclosure period of the third quarterly report, the performance of the two major sectors of the pharmaceutical industry was eye-catching
Time of Update: 2022-10-31
As of October 26, Wind data shows that a total of 141 A-share biopharmaceutical companies have disclosed three quarterly reports, of which 84 companies have achieved a year-on-year increase in net profit attributable to the parent in the first three quarters, accounting for 59.
-
After 15 years, the management measures for drug GLP certification will be overhauled!
Time of Update: 2022-10-31
Experimental animals used for non-clinical safety evaluation studies of drugs should indicate the specific names of the laboratory animal production licenses issued by the state and provide relevant supporting materials, and the quarantine situation shall include the recent health of the animal population and the results of pathogenic microorganism testing.
-
Pharmaceutical companies are strengthening the domestic substitution of upstream equipment, and pharmaceutical machinery companies will welcome the benefits
Time of Update: 2022-10-31
In recent years, with the growth of R&D investment by domestic biopharmaceutical enterprises and the promotion of a series of policies to encourage and encourage new drug research and development, the domestic biopharmaceutical industry is booming.
